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Recent epidemiologic studies have shown
that concentrations of ambient air particles
are associated with a wide range of effects on
human health, especially on the cardiorespira-
tory system (1–5). Some of the most persua-
sive data derive from epidemiologic
time-series studies of acute effects that
include inter alia investigations of daily
increases in hospital and emergency room
admissions (6–17) and increased daily
mortality (4,18–45). 
In addition to these studies of the short-
term effects of air pollution, three large
cohort studies that followed thousands of
subjects prospectively have been published
(46–51). The Six Cities Study (50) and the
American Cancer Society’s Cancer
Prevention Study II (51) were used to esti-
mate long-term associations between air pol-
lution and survival and have reported
increases in annual average total mortality
associated with fine particles. The Seventh
Day Adventist Health Study (46–49) showed
increases in respiratory diseases associated
with exposure to total suspended particles
(TSP) and particulate matter having an aero-
dynamic diameter of 10 µm or less (PM10),
although no associations with mortality have
been found (49). 
The health effects associated with short-
term increases in particulate pollution is rela-
tively small (1). Should air pollution affect all
individuals, this low risk would translate into
a serious public health problem. There is some
consensus that only persons in poor health
should experience severe and acute effects
(e.g., hospitalization, death) when levels of air
pollution increase (2,5,52,53). Thus, the iden-
tiﬁcation of susceptible subgroups is critically
important for scientiﬁc and public health pur-
poses, as it may provide information regarding
mechanisms and may target certain subgroups
to reduce exposure during episodes of high
levels of air pollution. The present mortality
time-series study addresses this issue by inves-
tigating whether individuals with speciﬁc res-
piratory and cardiovascular conditions
diagnosed before death had a higher mortality
when daily levels of particulate air pollution
were increased. 
Materials and Methods
The Study Population and Healthcare
Utilization Databases
We have described previously the method-
ology used in this study as well as reported
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associations between cause-speciﬁc mortality
and particles (54–56). In brief, the study pop-
ulation comprised all residents of Montreal,
Quebec, Canada, who died in the metropoli-
tan area from 1984 to 1993 and who were
registered with the universal Quebec Health
Insurance Plan (QHIP). Subjects were first
identiﬁed from the information provided by
the computerized provincial database of death
certificates, then each deceased subject was
linked to the population register of the
QHIP. Ethics approval was obtained from
the Institutional Review Board of McGill
University and from the Commission de
l’Accès à l’Information du Québec.
The Quebec Health Insurance Plan. This
record linkage provided detailed information
regarding medical services rendered by physi-
cians both in and out of hospital and reim-
bursed by the QHIP. The QHIP provides
universal coverage for all costs of medical ser-
vices dispensed in-province and provides
complete or partial coverage for services and
hospital admissions out-of-province.
Individuals are given unique health insurance
plan numbers that are recorded on each med-
ical transaction and used administratively to
check the validity of claims. Physicians in-
province are paid by the QHIP on a fee-for-
service basis, and out-of-province healthcare
is paid by the patient and reimbursed par-
tially or in full by the QHIP. This leads to
almost complete reporting to the QHIP.
Laboratory tests and results from these tests
are not part of the database. When submit-
ting each bill for service, the physician has the
option to record one diagnostic code using
the International Classiﬁcations of Diseases, 9th
Revision, Clinical Modifications (ICD-9-CM)
(57). Unlike the actual billing data, which are
examined by the QHIP for consistency and
accuracy, diagnoses are not verified. Most
physicians use a restricted set of ICD-9-CM
codes reﬂecting the mix of patients who con-
sult them. In addition, the QHIP pays the
costs of prescriptions for persons 65 years of
age and older. The information on dispensed
prescriptions includes date, name and generic
type of medication, quantity, duration of pre-
scription, and authorization for reﬁlls.
Ambient air pollution and weather data.
During the study period, measurements of
particulate air pollution TSP, particles having
aerodynamic diameters of 10 and 2.5 µm or
less [(PM10, PM2.5), and sulfates from these
metrics] were measured every 6 days at several
fixed-site monitoring stations in Montreal
(54–56,58,59). From July 1992 to September
1995, the measurement schedule for PM10
and PM2.5 was increased to daily sampling at
one site (58). Coefficient of haze (COH),
which measures organic and inorganic car-
bon, and gaseous pollutants were measured
every 2 hr. For the purposes of this study we
computed station-specific daily means from
these data and then averaged these across all
stations. We also used measurements of daily
total sulfates (1986–1993) from an acid rain
monitoring station at Sutton, Quebec, a rural
community about 150 km southeast of the
city (54). These data represent regional levels
throughout southwest Quebec, including
Montreal (58). The average correlation
between sulfates measured at this station and
the two Montreal stations was 0.9. 
We also developed statistical models for
the period from 1986 to 1993 to estimate ﬁne
particle mass and fine sulfate particles when
measurements were not taken, using the pre-
dictor variables COH, the extinction coeffi-
cient, and total sulfates from Sutton. The R2
for the prediction model for PM2.5 was 0.72
and for sulfates from PM2.5 it was 0.80.
Visibility, barometric pressure, tempera-
ture, total precipitation (distinguishing snow
from rain), relative humidity, and dew point
temperature were measured at Dorval
International Airport in Montreal. Visibility
at noon, or at other times of the day when
there was no precipitation, was converted
into an extinction coefficient (a measure of
light scattering and absorption) after account-
ing for relative humidity (25,54,55,60,61). 
Indicators of Disease Status
To define health conditions before death,
we used information from diagnoses
recorded on billing records, specific health
services rendered, and filled prescriptions
for drugs that are reimbursed by the QHIP.
We had on hand data for a period of up to
5 years before each death but wished to use
information as close to death as possible.
We therefore needed to select suitable time
periods that accounted for the typical
course of each disease and the manner in
which data were recorded on the billing and
prescription databases. Most chronic dis-
eases are not curable and persist for months
or years after initial detection, although
treatment can modify their natural history
and relieve symptoms, suggesting that rela-
tively long time periods could be used. On
the other hand, acute diseases such as pneu-
monia can resolve in a very short time. In
addition the average duration of a prescrip-
tion in the province of Quebec is about 1
month, so using an interval of less than 1
month to define disease status would lead to
a loss of important information. Also, diag-
noses were recorded on only about half of
the billing records. Because of the complex
method by which diagnoses were recorded
and drugs were prescribed, as well as the
intricate patterns in the utilization of
healthcare services, we felt that a 2-month
interval was the minimum for which we
could develop reasonably reliable indicators
of illness. In the end we used data during a
period of 2 months to define acute condi-
tions and a period of 1 year before death to
define chronic conditions. 
Respiratory diseases. Table 1 shows the
deﬁnitions for chronic upper respiratory dis-
eases, acute upper respiratory diseases, acute
lower respiratory diseases, and airways disease.
In defining airways disease we assumed that
the data from the QHIP were not sufﬁciently
specific to discriminate between asthma,
chronic bronchitis, and emphysema. In addi-
tion, because clinicians did not follow well-
deﬁned standards in prescribing drugs, we did
not discriminate by severity using dose or
quantity of drugs ﬁlled. 
Table 1. Deﬁnition of the indicators of respiratory disease status.
Services/tests/
procedures in 
Diagnoses (ICD-9-CM codesa)  Prescriptions in the speciﬁed 
Age (years) in speciﬁed time interval speciﬁed time interval time interval
Airways disease
< 65 and ≥ 65 ADa by a respirologist or None None
AD by a general practitioner  None ≥ 2 pulmonary 
or function tests
≥ 65  None Any prescription for bronchodilators 
(beta agonists, etc.), inhaled cortico-
steroids, systemic corticosteroids, 
anticholinergics, sodium chromo-
glycate (chromolyn), theophylline
Chronic upper respiratory
< 65 and ≥ 65 472–478, 102.3 None None
Acute upper respiratory
< 65 and ≥ 65 460–465 None None
Acute lower respiratory
< 65 and ≥ 65 466, 480–487, 512,  None None
513, 517.1, 518.0, 
518.4, 518.5, 519.0 
AD, airways disease. 
aThe following ICD-9-CM codes are used to represent AD: 490–496; 500–508; 518.1–518.3, 518.8; 519.1–519.3, 519.8, 519.9 (57).Susceptible subgroups and particulate air pollution
Cardiovascular diseases. Table 2 shows
the following indices of cardiovascular disease
status: hypertension, congestive heart failure,
acute coronary artery disease, chronic coro-
nary artery diseases, cerebrovascular diseases,
and chronic rheumatic heart diseases. A spe-
ciﬁc index was developed to capture coronary
bypass procedures. This was combined with
chronic and acute coronary artery disease to
form a composite index referred to as any
coronary artery disease (Table 3). Another
composite index included all of these cardio-
vascular indices (referred to as any cardiovas-
cular diseases). 
Statistical Methods
We created subgroups among subjects who
had any of the above-listed conditions and
analyzed daily mortality for those subjects
who did not die from accidents or injuries.
For each separate group we used quasi-
likelihood estimation within the context of
the generalized additive models (62) to model
the expected logarithm of daily counts of
deaths, assuming Poisson variation with con-
stant over- or underdispersion. We accounted
for seasonal and subseasonal variations (tem-
poral filter) using a locally weighted regres-
sion smoother (LOESS) on time, and we
adjusted for annual trends in daily mortality
and the potential confounding effects of rele-
vant weather variables. We selected the tem-
poral filter with a smoothing bandwidth
(span for the LOESS function) that produced
a filtered time series consistent with a white
noise process using Bartlett’s statistic (63). In
most cases this filter minimized the serial
autocorrelation and produced a minimum
Akaike information criterion. We then
selected the combination of weather variables
that explained the most amount of residual
variability in the data. Single-pollutant mod-
els using daily mean values across the fixed-
site monitoring stations were considered ﬁrst.
We also estimated mortality with the previ-
ous day’s level of air pollution (lag 1 day) as
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 4 | August 2001 489
Table 2. Deﬁnition of the indicators of cardiovascular disease status.
Services/tests/
Diagnoses (ICD-9-CM codesa)  Prescriptions in  procedures in the
Age (years) in speciﬁed time interval speciﬁed time interval speciﬁed time interval
Hypertension
< 65  401–405; ≥ 3 billings  None None
≥ 65 401–405; ≥ 3 billings or  None None
≥ 401–405; 2 billings  Any prescription for diuretics, beta-  None
blockers, calcium channel inhibitors, 
ACE inhibitors, vasodilators
Congestive heart failure
< 65  428; ≥ 2 billings  None None
≥ 65 428; ≥ 2 billings or  None None
428; ≥ 1 billing  Any prescription for diuretics None
Acute coronary artery disease
< 65 and ≥ 65 410, 411 None None
Chronic coronary artery disease
< 65  412–414 or None ≥ 1 Coronary catheteri-
zation or stress test
412–414; ≥ 3 billings or None None
412–414; diagnosed  None None
by a cardiologist
≥ 65 412–414 or None ≥ 1 Coronary catheteri-
zation or stress test
412–414; ≥ 3 billings or  None None
412–414; diagnosed by  None None
a cardiologist or
412–414 ≥ 2 Prescriptions for nitroglycerine None
Coronary artery bypass (chronic or acute) None 1 PTCA or coronary
bypass
Cerebrovascular diseases
< 65 and ≥ 65 430–438 None None
Chronic rheumatic heart disease
< 65 and ≥ 65 393–396 None None
Abbreviations: ACE, angiotensin-converting enzyme; ECG, electrocardiogram; PTCA, percutaneous transluminal coronary angioplasty.
aDiagnostic codes from ICD-9-CM (57).
Table 3. Composite cardiovascular indices. 
Composite Speciﬁc cardiovascular indices 
index included in the composite
Any coronary  Deﬁnite acute coronary artery disease
artery disease Chronic coronary artery disease
Coronary artery bypass
Any cardio- Acute coronary artery disease
vascular  Chronic coronary artery disease
disease Hypertension
Coronary artery bypass
Congestive heart failure
Cerebrovascular disease
Chronic rheumatic heart disease
Table 4. Distribution of daily nonaccidental mortality by subgroup, Montreal, Quebec, Canada, 1984–1993.
Number of days 
Total number  in which there  Percentiles
Subgroup of deaths were no deaths Mean Variance 25th 50th 75th 100th
All nonaccidental causes of death 133,904 0 36.7 51.5 32 36 41 89
< 65 years of age 31,756 0 8.7 9.1 7 8 11 22
≥ 65 years of age 102,148 0 28.0 40.2 24 28 32 79
Respiratory diseases
Acute upper respiratory disease 1,432 2,514 0.4 0.4 0 0 1 7
Chronic upper respiratory disease 2,541 1,869 0.7 0.8 0 0 1 6
Acute lower respiratory disease 15,775 85 4.3 6.0 2 4 6 17
Airways disease 29,030 7 7.9 11.0 6 8 10 23
Cardiovascular diseases
Acute coronary artery disease 9,900 258 2.7 2.9 1 3 4 12
Chronic coronary artery disease 22,176 12 6.1 6.4 4 6 8 17
Congestive heart failure 16,794 61 4.6 5.5 3 4 6 16
Hypertension 7,977 468 2.2 2.4 1 2 3 10
Cerebrovascular diseases 10,861 207 3.0 3.3 2 3 4 13
Any coronary artery disease 29,209 3 8.0 8.8 6 8 10 20
Any cardiovascular disease 52,357 0 14.3 17.7 11 14 17 34Goldberg et al.
490 VOLUME 109 | SUPPLEMENT 4 | August 2001 • Environmental Health Perspectives
well as with the average of lags 0–2 days
(referred to as the 3-day mean). For those
pollutants not measured daily, lags were taken
by shifting the mortality time series forward.
The 3-day mean could not be derived for pol-
lutants that were not monitored daily. 
We estimated parametric, linear terms
for the relative increase in the logarithmic
number of daily deaths per unit increase in
the pollutant. We calculated the percent
change in the mean number of daily deaths
for an increase of the interquartile range
(IQ) for each index of particle, i.e., as
[exp(β ×  IQ) – 1] ×  100%, where β is the
estimated regression coefficient. We refer to
this quantity as the mean percent change
(MPC). Associated upper and lower 95%
confidence intervals on the MPC were
obtained assuming that the estimated
regression coefficient was distributed nor-
mally, with the standard error corrected for
non-Poisson dispersion. 
Results
There were 133,904 nonaccidental deaths
during the study period 1984–1993 (Table 4),
with 76.3% of the deaths among the elderly.
One year before death, about 22% of the pop-
ulation were attributed with airways disease,
17% with chronic coronary artery disease, and
12% with congestive heart failure; for the
acute conditions (2 months before death),
12% had acute lower respiratory disease and
8% had strokes. 
Table 5. Distribution of pollutant and weather variables, Montreal, Quebec, Canada,1984–1993.
Number of 
days of  Percentiles
Units measurements Mean SD Minimum 25th 50th 75th  100th IQ
TSP µg/m3 603 53.1 22.6 14.6 37.0 48.7 65.6 211.1 28.57
PM10 µg/m3 624 32.2 17.6 6.5 19.7 28.5 41.1 120.5 21.32
PM2.5 µg/m3 636 17.4 11.4 2.2 9.4 14.7 21.9 72.0 12.51
Sulfate from PM10 µg/m3 437 4.7 4.4 0.3 1.9 3.6 5.7 30.7 3.84
Sulfate from PM2.5 µg/m3 446 4.3 4.2 0.2 1.6 3.1 5.1 29.2 3.51
Sulfate from TSP µg/m3 607 4.3 2.9 0.3 2.3 3.6 5.3 19.2 3.02
Sulfate from the Sutton  µg/m3 2,680 3.3 3.6 0 1.3 2.2 3.8 30.0 2.50
monitoring stationa
COH 0.1 COH units  3,653 2.4 1.5 0.1 1.3 2.1 3.2 15.6 1.85
per 327.8 
linear meters
Predicted PM2.5
a µg/m3 3,653 17.6 8.8 4.6 11.5 15.4 21.0 71.7 9.50
Predicted sulfate  µg/m3 3,653 4.1 3.6 0.02 1.9 3.1 4.8 30.1 2.90
from PM2.5
a
Extinction km–1 3,454 0.15 0.10 0.01 0.06 0.15 0.17 1.87 0.11
Sulfur dioxide µg/m3 3,653 17.8 11.2 3.9 10.3 14.6 21.8 105.7 11.50
Nitrogen dioxide µg/m3 3,653 41.7 15.4 8.8 30.9 39.5 50.2 143.5 19.34
Nitric oxide µg/m3 3,653 41.8 29.0 2.7 21.9 34.8 52.3 281.4 30.41
Carbon monoxide ppm 3,653 0.8 0.5 0.1 0.5 0.7 1.0 5.1 0.50
Ozone µg/m3 3,653 29.0 17.1 2.8 16.6 26.0 37.9 163.9 21.34
Mean temperature °C 3,653 6.4 11.8 –27.3 –2.6 7.5 16.5 28.8 19.10
Change in maximum  °C 3,653 0.0 4.7 –25.0 –2.5 0.4 2.8 19.4 5.30
temperature from the 
previous day
Mean dew point  °C 3,653 1.2 11.6 –33.8 –6.6 2.0 10.8 23.1 17.40
temperature
Relative humidity % 3,653 69.4 11.9 33.0 61.0 70.0 78.0 99.0 17.00
Change in barometric  kPa 3,653 0.0 0.9 –4.2 –0.5 0.0 0.6 4.4 1.10
pressure from 
previous day
aFor 1986–1993.
Table 6. Summary estimates of MPC in daily nonaccidental mortality for selected subgroups deﬁned using billing and prescription data obtained from the QHIP for their respec-
tive period prior to death, for three selected measures of particulate air pollution, across the IQ and evaluated at the 3-day mean, Montreal, Quebec, Canada, 1984–1993.a
COH Predicted PM2.5 Sutton sulfate
Subgroup MPCb 95% CI MPCb 95% CI MPCb 95% CI
All nonaccidental causes of death 1.98 1.07–2.90 2.17 1.26–3.08 1.29 0.68–1.90
Respiratory indices
Acute upper respiratory disease 4.57 –4.06–13.98 7.28 –1.12–16.40 6.36 0.58–12.47
Chronic upper respiratory disease 2.39 –3.78–8.97 3.81 –2.19–10.17 4.34 0.32–8.51
Acute lower respiratory disease 5.09 2.47–7.79 4.72 2.23–7.28 2.25 0.56–3.98
Airways disease 1.53 –0.39–3.49 1.33 –0.45–3.15 0.51 –0.72–1.75
Cardiovascular indices
Acute coronary artery disease 2.35 –0.91–5.70 2.27 –0.88–5.52 0.99 –1.17–3.19
Chronic coronary artery disease 2.62 0.53–4.75 2.20 0.14–4.31 0.63 –0.77–2.06
Congestive heart failure 4.99 2.44–7.60 4.02 1.61–6.48 1.91 0.28–3.56
Hypertension 3.35 –0.27–7.10 1.88 –1.56–5.44 0.53 –1.80–2.92
Cerebrovascular disease 1.73 –1.35–4.91 1.53 –1.40–4.55 0.63 –1.37–2.66
Any coronary artery disease 2.99 1.13–4.88 1.85 0.03–3.70 0.69 –0.55–1.95
Any cardiovascular disease 3.65 2.23–5.09 2.76 1.40–4.15 1.16 0.23–2.09
aThe statistical model was E(log(yi)) = α + loess(i, span = 91/3653) + loess(year) + loess(mean temperature0, change in barometric pressure from the previous 24 hr0) + β× pollutant, where yi is the number
of nonaccidental deaths on day i for subjects included in each subgroup. bMPCs calculated for an increase of exposure equal to the IQ.Susceptible subgroups and particulate air pollution
Table 5 shows that the levels of particulate
and gaseous pollutants were fairly low.
Measurements for TSP, PM10, PM2.5, and sul-
fates from these metrics were limited (varying
from 12 to 17% of the total number of days
on study), and there were 8 of 10 years of mea-
surements of Sutton sulfates (1986–1993).
Table 6 shows detailed results for each
morbidity subgroup (all age groups com-
bined) of the regression analyses for three
selected measures of particles evaluated at the
3-day mean. For the purposes of comparison
we have included the results for all nonacci-
dental causes of death. (All positive associa-
tions were consistent with a linear response
function.) We did not find any consistent
positive associations (95% confidence inter-
vals for the MPCs excluding zero across all
metrics of particles) among persons who were
classiﬁed before death as having airways dis-
ease, acute coronary artery disease, hyperten-
sion, or cerebrovascular disease. Although we
found positive associations with Sutton sul-
fates among persons with acute and chronic
upper respiratory diseases, no associations for
this or any other pollutant were found at lag
0 or lag 1 days (Table 7). Consistent associa-
tions, when evaluated at the 3-day mean and
for most measures of particles evaluated at lag
1 day, were found for the subgroup with
acute lower respiratory disease. The subgroup
with chronic coronary artery diseases was not
found to be consistently associated across the
different indices of particles or lags. We
found a consistent association for congestive
heart failure evaluated at the 3-day mean as
well as at lag 0 days. Last, associations in the
combined subgroup of individuals with any
cardiovascular diseases were found across all
indices of exposure and lags.
Figures 1–3 show results for selected
measures of particles evaluated at the 3-day
mean for deaths from acute lower respiratory
disease, chronic coronary artery disease, and
any cardiovascular diseases by age at time of
death (< 65 and ≥ 65 years), respectively. We
do not show results for congestive heart fail-
ure for the former age group as there were too
few deaths. The ﬁgures show rather large con-
fidence intervals that reflect the statistical
noise inherent in these time-series analyses,
particularly for the younger age groups. We
did not ﬁnd large differences between the age
groups for subjects with acute lower respira-
tory diseases attributed within 2 months
before their deaths (Figure 1). Although no
consistent associations were found for chronic
coronary artery diseases in the analyses of all
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Table 7. Synthesis of selected results of the MPC for the different subgroups of disease status for selected mea-
sures of particulates evaluated at the IQ for lag 0 and lag 1 days, Montreal, Quebec, Canada, 1984–1993.
Sulfate Predicted
Predicted from sulfate 
Subgroup COH Extinction PM2.5 Sutton from PM2.5
Lag 0 days
All nonaccidental causes of death 1.44* 1.05* 1.86* 0.71* 1.15*
Respiratory indices
Acute upper respiratory disease 1.66 –1.58 4.08 3.30 3.64
Chronic upper respiratory disease –0.33 –4.15 –0.08 0.56 –0.08
Acute lower respiratory disease 1.04 1.42 2.12* 1.09 1.52
Airways disease 0.61 1.24 1.47* 0.14 0.90
Cardiovascular indices
Acute coronary artery disease 1.51 1.06 1.94 0.43 0.95
Chronic coronary artery disease 1.76* 1.11 1.66 0.41 0.85
Congestive heart failure 2.88* 2.98* 3.44* 1.67* 2.61*
Hypertension 1.65 1.53 1.97 0.23 1.12
Cerebrovascular disease 0.69 0.53 1.72 0.42 0.88
Any coronary artery disease 1.40 0.66 1.74* 0.73 1.02
Any cardiovascular disease 1.82* 1.10* 2.05* 0.72 1.19*
Lag 1 day
All nonaccidental causes of death 1.12* 0.86* 1.48* 0.95* 1.15*
Respiratory indices
Acute upper respiratory disease 3.72 0.68 5.14 3.73 4.11
Chronic upper respiratory disease 2.92 –2.32 1.39 1.64 0.63
Acute lower respiratory disease 4.38* 0.59 3.27* 1.83* 1.86*
Airways disease 1.44 1.41* 1.11 0.60 0.95
Cardiovascular indices
Acute coronary artery disease 2.31 0.70 2.38 0.68 1.09
Chronic coronary artery disease 1.98* 0.25 1.82* 0.66 0.98
Congestive heart failure 4.17* 1.58 2.81* 1.18 1.53*
Hypertension 1.99 0.57 0.34 0.14 0.23
Cerebrovascular disease 1.71 0.96 1.77 1.03 1.13
Any coronary artery disease 2.56* 0.35 1.60* 0.30 0.61
Any cardiovascular disease 2.95* 1.14* 2.49* 1.11* 1.52*
*t > 1.96.
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Figure 1. MPC in daily mortality among persons with
acute lower respiratory diseases 2 months before death,
evaluated at the 3-day mean for increases in the IQs of
selected measures of particulates, by age group. The
estimated MPC in daily nonaccidental mortality across
the IQ is shown by the circles within the vertical lines
(95% CIs).
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Figure 2. MPC in daily mortality among persons with
chronic coronary artery diseases 1 year before death,
evaluated at the 3-day mean for increases in the IQs of
selected measures of particulates, by age group. The esti-
mated MPC in daily nonaccidental mortality across the IQ
is shown by the horizontal bars within the vertical lines
(95% CIs).
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Figure 3. MPC in daily mortality among persons with
any cardiovascular diseases 1 year before death, evalu-
ated at the 3-day mean for increases in the IQs of
selected measures of particulates, by age group. The
estimated MPC in daily nonaccidental mortality across
the IQ is shown by the circles within the vertical lines
(95% CIs).Goldberg et al.
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age groups, positive associations among the
elderly were found (Figure 2). There was a
clear increase in daily mortality among the
elderly who had any cardiovascular diseases
(Figure 3).
We also adjusted for the separate effects of
sulfur dioxide and ozone (all pollutants evalu-
ated at the 3-day mean). Figure 4 shows that
the association for the subgroup with conges-
tive heart failure (all age groups) was, in gen-
eral, attenuated by these adjustments. Similar
results were found for the subgroup with
acute lower respiratory diseases (data not
shown). Figure 5 shows that for congestive
heart failure the positive associations were
restricted to the summer season (April–
September). Similar results were found for
acute lower respiratory diseases but not for
chronic coronary artery disease in the elderly
(data not shown).
Discussion
In summary, statistically significant positive
associations were found for individuals who,
shortly before death, were classiﬁed as having
acute lower respiratory diseases, congestive
heart failure, and a combined group of car-
diovascular diseases. There was reasonable
evidence that individuals with chronic coro-
nary artery disease (especially in the elderly)
also had higher daily mortality when air pol-
lution increased. (Positive associations were
found for all measures of particles except sul-
fates.) In addition, there was evidence that
the effects of air pollution in these subgroups
were greater in the summer season than in the
winter. These results need to be interpreted in
terms of the study’s strengths and limitations. 
Methodologic Aspects
Pollution data. Data for particle mass were
limited by the 6-day measurement schedule, so
we relied on the COH, which is a reliable
measure of the concentration of ambient
carbon particles (mostly from internal combus-
tion), the extinction coefﬁcient (which primar-
ily measures sulfate), and sulfate from the
Sutton acid rain monitoring station. The
extinction coefﬁcient is likely to be misclassi-
fied more than particle mass because of the
subjectivity of the measurements of visibility
and the approximate formula used to convert
visibility into an extinction measure.
Measurements of total sulfate at the Sutton
acid rain station captured regional levels of sul-
fates, but despite the high correlation with
measurements of sulfate in Montreal, these
regional levels did not fully reflect levels in
Montreal because the measurements did not
capture local ﬂuctuations. As we did not have a
complete series of ﬁne particle measurements,
we created one using a linear regression model
that included COH, sulfate from the Sutton
monitoring station, and the extinction coefﬁ-
cient. Although the statistical models provided
reasonably good predictions, misclassiﬁcation
of this index should also have reduced power
and attenuated estimates of effect. 
Confounding. We adjusted for seasonal
and subseasonal cycles in the mortality time
series as well as the effects of weather on daily
mortality. We could not control for the
effects of infectious disease epidemics (e.g.,
inﬂuenza, which occurs mostly in the fall and
winter, when particle levels are increased).
However, because these epidemics generally
follow seasonal and subseasonal weather pat-
terns, it seems plausible that some or all of
these potential confounding effects were
removed during the temporal filtering. In a
few other studies adjustment for influenza
epidemics did not remove associations
between mortality and suspended particles or
sulfur dioxide (64–66).
We also adjusted for the effects of the
gaseous pollutants. Many of these pollutants
are generated from complex chemical
reactions in air (e.g., ozone), and some
gaseous pollutants (e.g., sulfur dioxide) act as
precursors in the formation of particles.
These atmospheric chemical processes create
high correlations among levels of most pollu-
tants. As the sources for the pollutants are the
same, care must be taken in interpreting the
results of these adjustments. 
Morbidity data. The data used to
construct the indices of disease status con-
sisted of healthcare billing data, diagnostic
codes recorded on the billing record, ren-
dered healthcare services, and ﬁlled prescrip-
tions for drugs that were paid for by the
QHIP. Because the data are based on ren-
dered services carried out both within and
outside the hospital, they should, in principle,
perform more accurately than simple hospital
discharge summaries, which provide, at best,
a snapshot of acute illnesses or exacerbations
of chronic ones. 
The key assumption in using the QHIP
data was that they were sufficiently accurate
to define most conditions before death. In
deﬁning these indices we used our knowledge
of clinical practice in Quebec. For example,
the requirement of having three diagnoses on
the billing record to deﬁne hypertension was
based on usual clinical practice guidelines.
We also assumed that certain conditions
could not be identiﬁed uniquely; for example,
we defined airways disease but did not
attempt to identify its individual components
(e.g., asthma). 
An essential element in defining most of
the indices of disease status was the diagnosis
recorded on the billing record. Although this
was available for only about 50% of the
billing records, over 97% of deceased subjects
had at least one diagnosis coded in the 5-year
period before death. There are no data
regarding the accuracy of these diagnoses.
However, it seems plausible that diagnoses for
cancer and stroke should be accurate because
of well-established investigative procedures
used by specialists, whereas the accuracy of
diagnosing asthma would be more problem-
atic because appropriate tests would not be
conducted by all physicians. 
The next most important indicator was
records of filled prescriptions. Although we
had no information regarding compliance for
taking drugs, this may be irrelevant in the con-
text of defining subgroups, as we were only
interested in whether a prescription indicated
the presence of a speciﬁc health condition. On
the other hand, we had no information regard-
ing prescriptions written by physicians but
never filled by patients; this kind of missing
information will inevitably lead to misclassiﬁ-
cation that may vary by disease and socioeco-
nomic status. Because the drug plan covered
persons who were 65 years of age and older,
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there was limited prescription data for persons
who died at age 65. It would have been useful
to carry out analyses excluding persons who
died exactly at the age of 65 years, but this was
not possible because the QHIP did not pro-
vide us with exact ages of subjects (only in
groupings of 5 years; for reasons of conﬁden-
tiality). Thus, it is likely that there were some
inaccuracies in classifying subjects into
subgroups based on prescriptions.
We used a 2-month interval to capture
acute conditions and a 1-year period to cap-
ture chronic conditions. These intervals trade
off specificity and sensitivity and account
qualitatively for the complex manner in
which information is recorded in the billing
databases. Our analyses for chronic disease
[data not shown; (54)] indicated that there
could be substantial loss of information if too
short a period was used. On the other hand,
the 2-month period for acute diseases seemed
justiﬁed, although it resulted in rather sparse
time series of deaths for some conditions. 
Mechanisms. Bates (2) suggested that
exposure to air pollutants in persons with car-
diac disease with myocardial damage may
cause acute pulmonary disease such as bron-
chiolitis or pneumonia, thereby leading to
congestive heart failure. In addition, Seaton et
al. (52) hypothesized that in susceptible indi-
viduals, exposure to ultrafine particles will
invoke alveolar inﬂammation, release inﬂam-
matory mediators, exacerbate lung conditions,
and increase coagulability of blood, thereby
leading to acute cardiovascular events. These
hypotheses suggest that persons with conges-
tive heart failure and acute myocardial infarc-
tions should die at higher rates when air
pollution increases. Based on this extension of
these hypotheses, our results appear to be
more consistent with the hypothesis of Bates
(2), and the null association with acute coro-
nary artery disease is not consistent with the
hypothesis of Seaton et al. (52).
Other mechanisms may be at play. It has
been shown that inhalation of urban parti-
cles in animals not having a structural lung
injury increases the circulating levels of
endothelins, the most potent vasoconstric-
tors known (67). Elevation of circulating
endothelin-1 and endothelin-3 has been
reported in a number of conditions, includ-
ing cardiovascular disease, asthma, and dia-
betes. These peptides have vasoconstrictor as
well as mitogenic effects and may be
involved in the pathogenesis of a number of
conditions. In particular, it has been
reported that plasma endothelin levels corre-
late with severity of disease in congestive
heart failure and predict cardiac death (68).
Likewise, reduction of endothelin levels in
congestive heart failure patients was associ-
ated with improvement of symptoms, sug-
gesting a direct role of endothelins in the
pathophysiology (69). The toxicologic data
suggest that ambient particles and particle-
associated chemical species may act princi-
pally as endocrine/paracrine modulators;
host factors will modulate these and establish
the nature and severity of the health effects. 
One can postulate that ambient particles
may affect the heart indirectly by a modiﬁca-
tion of endothelin homeostasis in the lungs.
Conceivably, elevated circulating endothelins
would impact on cardiac arrhythmia and dys-
rhythmia, exacerbate congestive heart failure,
precipitate ischemic heart disease, and may
affect persons with conditions involving
endothelial dysfunction such as diabetes,
atherosclerosis, and kidney diseases. 
Because this study is the ﬁrst of its kind,
the findings need to be replicated. In addi-
tion, in-depth studies of individuals need to
be undertaken to determine whether the asso-
ciation is causal. Speciﬁcally, if one can show
in a panel study or other appropriate design
that changes in essential indicators of health
status that are precursors to acute crises (hos-
pitalization, death) are associated with varia-
tions in levels of air pollution, then the case
for causality is greatly strengthened. 
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